Welcome to CSNpharm! For Research Use Only!

Cholecystokinin Receptor

Cholecystokinin Receptor

Cat. No. Product Name CAS No. Information
CSN26386 YM022 145084-28-2 YM022 is a highly potent, selective and orally active gastrin/cholecystokinin (CCK)-B receptor (CCK-BR) antagonist. YM022 shows the Ki values of 68 pM and 63 nM for CCK-B and CCK-A receptor, respectively[1]. YM022 can inhibit gastrin-induced gastric acid secretion and histidine decarboxylase activation in vivo[3].
CSN22513 SR 146131 221671-61-0 SR 146131 is a potent, orally active and selective nonpeptide cholecystokinin subtype 1 receptor agonist on IMR-32 human neuroblastoma cells.
CSN23839 Proglumide 6620-60-6 Proglumide is a known cholecystokinin (CCK) antagonist.
CSN18099 Nastorazepide 209219-38-5 Nastorazepide is a selective orally available 15-benzodiazepine-derivative gastrincholecystokinin 2 CCK-2 receptor antagonist with potential antineoplastic activity
CSN21716 Loxiglumide 107097-80-3 Loxiglumide is a cholecystokinin (CCK) receptor antagonist.
CSN26412 Devazepide 103420-77-5 Devazepide is a potent, competitive, selective and orally active nonpeptide antagonist of cholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245 nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. Devazepide is effective for gastrointestinal disorders[1].
<< PREV 1 NEXT >>